The emergence of new targets and new technologies, treatment prospects can be expected: 2016 review of progress in drug research and development
文献类型:期刊论文
作者 | Liu Lili; Mao Yanyan; Gao Liubin![]() |
刊名 | Science & Technology Review
![]() |
出版日期 | 2017 |
卷号 | 35期号:1页码:100-106 |
关键词 | tumor cardiovascular disease diabetes drug target frontier of pharmacy |
ISSN号 | 1000-7857 |
其他题名 | 新靶点新技术涌现,精准治疗前景可期2016药物研发热点回眸 |
文献子类 | Article |
英文摘要 | Medicine is a kind of special product that relates to national health, social stability and economic development. In recent years, the pharmaceutical industry has become one of the fastest growing industries in the national economy. In 2016, the pharmaceutical industry continued its prosperity and exhibited many new characteristics. This paper, based on the new heavy drugs approved in the year, summarizes the new targets, new technologies, new methods and so on, in the fields of cancer, diabetes, cardiovascular disease, Alzheimer's disease, autoimmune diseases and infectious diseases. |
WOS研究方向 | Pharmacology & Pharmacy (provided by Clarivate Analytics) |
语种 | 中文 |
CSCD记录号 | CSCD:5912346 |
源URL | [http://119.78.100.183/handle/2S10ELR8/269216] ![]() |
专题 | 信息中心 |
通讯作者 | Liu Lili; Gao Liubin |
作者单位 | Information Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. |
推荐引用方式 GB/T 7714 | Liu Lili,Mao Yanyan,Gao Liubin. The emergence of new targets and new technologies, treatment prospects can be expected: 2016 review of progress in drug research and development[J]. Science & Technology Review,2017,35(1):100-106. |
APA | Liu Lili,Mao Yanyan,&Gao Liubin.(2017).The emergence of new targets and new technologies, treatment prospects can be expected: 2016 review of progress in drug research and development.Science & Technology Review,35(1),100-106. |
MLA | Liu Lili,et al."The emergence of new targets and new technologies, treatment prospects can be expected: 2016 review of progress in drug research and development".Science & Technology Review 35.1(2017):100-106. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。